AstraZeneca globally withdraws Covid-19 vaccine from circulation due to safety concerns
Shorts By/
Shefali Dhiman
May 8, 2024
AstraZeneca is globally withdrawing its COVID-19 vaccine, Vaxzevria, due to a surplus of advanced vaccines targeting virus variants. The company cited decreased demand and potential side effects, including rare blood clotting. Withdrawal followed a decline in production and supply, effective from May 7.